Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_assertion type Assertion NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_head.
- NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_assertion wasGeneratedBy ECO_0000203 NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_provenance.
- NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_assertion wasDerivedFrom befree-20140225 NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_provenance.
- NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_assertion SIO_000772 12699242 NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_provenance.
- NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_assertion evidence source_evidence_literature NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_provenance.
- NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_assertion description "[Seventy-four patients (63%) had eythrocyte UROD activity within the normal range (74% to 126% of the mean activity of 43 healthy controls) and were classified as sporadic-PCT (47%) or as type III-PCT (16%) whenever a family history of PCT was documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206506.RAqkHMFZYKq6chuAPAcUMLbF98USVyH5hMpRTzeKUN_0g130_provenance.